Report Detail
Global Avian Influenza Vaccines Market Growth 2019-2024
- RnM2930606 |
- 12 February, 2019 |
- Global |
- 138 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.
The global average price of Avian Influenza Vaccines is in the decreasing trend, from 20 K USD/K doses in 2011 to 19.8 USD/K doses in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Avian Influenza Vaccines includes H5 Avian Influenza Vaccines, H9 Avian Influenza Vaccines and other Avian Influenza Vaccines, and the proportion of H5 Avian Influenza Vaccines in 2015 is about 73%, and the proportion is in decreasing trend from 2011 to 2015.
Avian Influenza Vaccines is widely used in Chicken, Duck & Goose and Other birds. The most proportion of Avian Influenza Vaccines is used in chicken, and the production proportion in 2015 is about 77%.
China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49% in 2015. Asia (Ex. China) is the second largest supplier of Avian Influenza Vaccines, enjoying production market share nearly 23% in 2015.
China is the largest consumption place, with a consumption market share nearly 45% in 2015. Following China, Asia (Ex. China) is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Merial, QYH Biotech, DHN, HVRI, CEVA, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Avian Influenza Vaccines market will register a 2.5% CAGR in terms of revenue, the global market size will reach US$ 120 million by 2024, from US$ 100 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Avian Influenza Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Avian Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
This study considers the Avian Influenza Vaccines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type H5
Type H9
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Chicken
Duck & Goose
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merial
CEVA
Zoetis
Elanco (Lohmann )
Merck Animal Health
Avimex Animal Health
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Avian Influenza Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Avian Influenza Vaccines market by identifying its various subsegments.
Focuses on the key global Avian Influenza Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Avian Influenza Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Avian Influenza Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Avian Influenza Vaccines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Avian Influenza Vaccines Consumption 2014-2024
- 2.1.2 Avian Influenza Vaccines Consumption CAGR by Region
- 2.2 Avian Influenza Vaccines Segment by Type
- 2.2.1 Type H5
- 2.2.2 Type H9
- 2.2.3 Other
- 2.3 Avian Influenza Vaccines Consumption by Type
- 2.3.1 Global Avian Influenza Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Avian Influenza Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Avian Influenza Vaccines Sale Price by Type (2014-2019)
- 2.4 Avian Influenza Vaccines Segment by Application
- 2.4.1 Chicken
- 2.4.2 Duck & Goose
- 2.4.3 Other
- 2.5 Avian Influenza Vaccines Consumption by Application
- 2.5.1 Global Avian Influenza Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Avian Influenza Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Avian Influenza Vaccines Sale Price by Application (2014-2019)
3 Global Avian Influenza Vaccines by Players
- 3.1 Global Avian Influenza Vaccines Sales Market Share by Players
- 3.1.1 Global Avian Influenza Vaccines Sales by Players (2017-2019)
- 3.1.2 Global Avian Influenza Vaccines Sales Market Share by Players (2017-2019)
- 3.2 Global Avian Influenza Vaccines Revenue Market Share by Players
- 3.2.1 Global Avian Influenza Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global Avian Influenza Vaccines Revenue Market Share by Players (2017-2019)
- 3.3 Global Avian Influenza Vaccines Sale Price by Players
- 3.4 Global Avian Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Avian Influenza Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Avian Influenza Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Avian Influenza Vaccines by Regions
- 4.1 Avian Influenza Vaccines by Regions
- 4.1.1 Global Avian Influenza Vaccines Consumption by Regions
- 4.1.2 Global Avian Influenza Vaccines Value by Regions
- 4.2 Americas Avian Influenza Vaccines Consumption Growth
- 4.3 APAC Avian Influenza Vaccines Consumption Growth
- 4.4 Europe Avian Influenza Vaccines Consumption Growth
- 4.5 Middle East & Africa Avian Influenza Vaccines Consumption Growth
5 Americas
- 5.1 Americas Avian Influenza Vaccines Consumption by Countries
- 5.1.1 Americas Avian Influenza Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas Avian Influenza Vaccines Value by Countries (2014-2019)
- 5.2 Americas Avian Influenza Vaccines Consumption by Type
- 5.3 Americas Avian Influenza Vaccines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Avian Influenza Vaccines Consumption by Countries
- 6.1.1 APAC Avian Influenza Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC Avian Influenza Vaccines Value by Countries (2014-2019)
- 6.2 APAC Avian Influenza Vaccines Consumption by Type
- 6.3 APAC Avian Influenza Vaccines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Avian Influenza Vaccines by Countries
- 7.1.1 Europe Avian Influenza Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe Avian Influenza Vaccines Value by Countries (2014-2019)
- 7.2 Europe Avian Influenza Vaccines Consumption by Type
- 7.3 Europe Avian Influenza Vaccines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Avian Influenza Vaccines by Countries
- 8.1.1 Middle East & Africa Avian Influenza Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Avian Influenza Vaccines Value by Countries (2014-2019)
- 8.2 Middle East & Africa Avian Influenza Vaccines Consumption by Type
- 8.3 Middle East & Africa Avian Influenza Vaccines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Avian Influenza Vaccines Distributors
- 10.3 Avian Influenza Vaccines Customer
11 Global Avian Influenza Vaccines Market Forecast
- 11.1 Global Avian Influenza Vaccines Consumption Forecast (2019-2024)
- 11.2 Global Avian Influenza Vaccines Forecast by Regions
- 11.2.1 Global Avian Influenza Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global Avian Influenza Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Avian Influenza Vaccines Forecast by Type
- 11.8 Global Avian Influenza Vaccines Forecast by Application
12 Key Players Analysis
- 12.1 Merial
- 12.1.1 Company Details
- 12.1.2 Avian Influenza Vaccines Product Offered
- 12.1.3 Merial Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Merial News
- 12.2 CEVA
- 12.2.1 Company Details
- 12.2.2 Avian Influenza Vaccines Product Offered
- 12.2.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 CEVA News
- 12.3 Zoetis
- 12.3.1 Company Details
- 12.3.2 Avian Influenza Vaccines Product Offered
- 12.3.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Zoetis News
- 12.4 Elanco (Lohmann )
- 12.4.1 Company Details
- 12.4.2 Avian Influenza Vaccines Product Offered
- 12.4.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Elanco (Lohmann ) News
- 12.5 Merck Animal Health
- 12.5.1 Company Details
- 12.5.2 Avian Influenza Vaccines Product Offered
- 12.5.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Merck Animal Health News
- 12.6 Avimex Animal Health
- 12.6.1 Company Details
- 12.6.2 Avian Influenza Vaccines Product Offered
- 12.6.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Avimex Animal Health News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Avian Influenza Vaccines . Industry analysis & Market Report on Avian Influenza Vaccines is a syndicated market report, published as Global Avian Influenza Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Avian Influenza Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
